Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil

Journal of Affective Disorders

Volumn 113, Issue 1-2, 2009, Pages 45-55

  Gos, Tomasz ^a,b   Günther, Karoline ^b   Bielau, Hendrik ^b   Dobrowolny, Henrik ^b   Mawrin, Christian ^b   Trübner, Kurt ^c   Brisch, Ralf ^b   Steiner, Johann ^b   Bernstein, Hans Gert ^b   Jankowski, Zbigniew ^a   Bogerts, Bernhard ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Depression; GAD; Postmortem; Suicide

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DIAZEPAM; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; LITHIUM; PARAFFIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN; CINGULATE GYRUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; ENTORHINAL CORTEX; FEMALE; GABAERGIC SYSTEM; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KRUSKAL WALLIS TEST; LIFESPAN; MALE; MOOD DISORDER; NEUROPIL; ORBITAL CORTEX; POST HOC ANALYSIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANK SUM TEST; RELATIVE DENSITY; SUICIDE; THALAMUS NUCLEUS;

ADOLESCENT; ADULT; AGED; BRAIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; FUNCTIONAL LATERALITY; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE DEGENERATION; NEUROPIL; SUICIDE;

EID: 58149093523     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.04.021     Document Type: Article

References (69)

1. Akbarian S., and Huang H.S. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 52 (2006) 293-304
2. Arango V., Underwood M.D., and Mann J.J. Serotonin brain circuits involved in major depression and suicide. Prog. Brain Res. 136 (2002) 443-453
3. Arellano J.I., Munoz A., Ballesteros-Yanez I., Sola R.G., and DeFelipe J. Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain 127 (2004) 45-64
4. Baumann B., Danos P., Diekmann S., Krell D., Bielau H., Geretsegger C., Wurthmann C., Bernstein H.G., and Bogerts B. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients. Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999) 212-219
5. Bausch S.B. Axonal sprouting of GABAergic interneurons in temporal lobe epilepsy. Epilepsy & Behav. 7 (2005) 390-400
6. Beasley C.L., Zhang Z.J., Patten I., and Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 52 (2002) 708-715
7. Benagiano V., Lorusso L., Coluccia A., Tarullo A., Flace P., Girolamo F., Bosco L., Cagiano R., and Ambrosi G. Glutamic acid decarboxylase and GABA immunoreactivities in the cerebellar cortex of adult rat after prenatal exposure to a low concentration of carbon monoxide. Neuroscience 135 (2005) 897-905
8. Benes F.M., Todtenkopf M.S., and Logiotatos P. Williams M. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20 (2000) 259-269
9. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am. J. Psychiatry 161 (2004) 368-370
10. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., and Cowen P.J. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry 61 (2007) 806-812
11. Bielau H., Mawrin C., Krell D., Agelink M.W., Trübner K., Davis R., Gos T., Bogerts B., Bernstein H.G., and Baumann B. Differences in activation of the dorsal raphe nucleus depending on performance of suicide. Brain Res. 1039 (2005) 43-52
12. Bielau H., Steiner J., Mawrin C., Trübner K., Brisch R., Meyer-Lotz G., Brodhun M., Dobrowolny H., Baumann B., Gos T., Bernstein H.G., and Bogerts B. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study. Ann. N.Y. Acad. Sci. 1096 (2007) 157-169
13. Bowers G., Cullinan W.E., and Herman J.P. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. J. Neurosci. 18 (1998) 5938-5947
14. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 8 (2003) 721-737
15. Campbell S., and MacQueen G. The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 29 (2004) 417-426
16. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., Myers R.M., Bunney Jr. W.E., Akil H., Watson S.J., and Jones E.G. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15653-15658
17. Cotter D., Landau S., Beasley C., Stevenson R., Chana G., MacMillan L., and Everall I. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol. Psychiatry 51 (2002) 377-386
18. Cuellar A.K., Johnson S.L., and Winters R. Distinctions between bipolar and unipolar depression. Clin. Psychol. Rev. 25 (2005) 307-339
19. Davidson R.J., Lewis D.A., Alloy L.B., Amaral D.G., Bush G., Cohen J.D., Drevets W.C., Farah M.J., Kagan J., McClelland J.L., Nolen-Hoeksema S., and Peterson B.S. Neural and behavioral substrates of mood and mood regulation. Biol. Psychiatry 52 (2002) 478-502
20. Dent G., Choi D.C., Herman J.P., and Levine S. GABAergic circuits and the stress hyporesponsive period in the rat: ontogeny of glutamic acid decarboxylase (GAD) 67 mRNA expression in limbic-hypothalamic stress pathways. Brain Res. 1138 (2007) 1-9
21. Dracheva S., Elhakem S.L., McGurk S.R., Davis K.L., and Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J. Neurosci. Res. 76 (2004) 581-592
22. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 48 (2000) 813-829
23. Ebmeier K.P., Donaghey C., and Steele J.D. Recent developments and current controversies in depression. Lancet 367 (2006) 153-167
24. Fagiolini M., and Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 404 (2000) 183-186
25. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr. Res. 72 (2005) 109-122
26. Freichel C., Potschka H., Ebert U., Brandt C., and Loscher W. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience 141 (2006) 2177-2194
27. Freund T.F. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci. 26 (2003) 489-495
28. Ge S., Pradhan D.A., Ming G.L., and Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci. 30 (2007) 1-8
29. Gilliam F.G., Santos J., Vahle V., Carter J., Brown K., and Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?. Epilepsia 45 Suppl 2 (2004) 28-33
30. Gos T., Becker K., Bock J., Malecki U., Bogerts B., Poeggel G., and Braun K. Early neonatal and postweaning social emotional deprivation interferes with the maturation of serotonergic and tyrosine hydroxylase-immunoreactive afferent fiber systems in the rodent nucleus accumbens, hippocampus and amygdala. Neuroscience 140 (2006) 811-821
31. Gos T., Krell D., Brisch R., Bielau H., Trübner K., Bernstein H.G., and Bogerts B. The changes of AgNOR parameters of anterior cingulate pyramidal neurons are region-specific in suicidal and non-suicidal depressive patients. World J. Biol. Psychiatry 8 (2007) 245-255
32. Gos T., Krell D., Brisch R., Bielau H., Trübner K., Bernstein H.G., and Bogerts B. The changes in AgNOR parameters of dorsal raphe nucleus neurons are related to suicide. Leg. Med. (Tokyo) 9 (2007) 251-257
33. Gos T., Krell D., Brisch R., Bielau H., Trübner K., Steiner J., Bernstein H.G., and Bogerts B. Demonstration of decreased activity of dorsal raphe nucleus neurons in depressed suicidal patients by the AgNOR staining method. J. Affect. Disord. 111 (2008) 251-260
34. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., and Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000) 1061-1069
35. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Veldic M., Zhang X., and Costa E. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology 180 (2005) 191-205
36. Hahn C.G., Gyulai L., Baldassano C.F., and Lenox R.H. The current understanding of lamotrigine as a mood stabilizer. J. Clin. Psychiatry 65 (2004) 791-804
37. Hajszan T., and MacLusky N.J. Neurologic links between epilepsy and depression in women: is hippocampal neuroplasticity the key?. Neurology 66 Suppl 3 (2006) 13-22
38. Heckers S., Stone D., Walsh J., Shick J., Koul P., and Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59 (2002) 521-529
39. Ishikawa M., Mizukami K., Iwakiri M., Hidaka S., and Asada T. Immunohistochemical and immunoblot study of GABA (A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci. Res. 50 (2004) 77-84
40. Ishikawa M., Mizukami K., Iwakiri M., and Asada T. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci. Lett. 383 (2005) 272-277
41. Jacobs B.L., Praag H., and Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 5 (2000) 262-269
42. Kanner A.M. Is major depression a neurologic disorder with psychiatric symptoms?. Epilepsy Behav. 5 (2004) 636-644
43. Laprade N., and Soghomonian J.J. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33 (1999) 36-48
44. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6 (2005) 312-324
45. Lisman J.E., and Otmakhova N.A. Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine. Hippocampus 11 (2001) 551-568
46. Lyoo I.K., Sung Y.H., Dager S.R., Friedman S.D., Lee J.Y., Kim S.J., Kim N., Dunner D.L., and Renshaw P.F. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord. 8 (2006) 65-74
47. Mann J.J. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 4 (2003) 819-828
48. McEwen B.S., Magarinos A.M., and Reagan L.P. Structural plasticity and tianeptine: cellular and molecular targets. Eur. Psychiatry 17 Suppl 3 (2002) 318-330
49. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., and Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 24 (2004) 1478-1485
50. Molnar M., Potkin S.G., Bunney W.E., and Jones E.G. MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol. Psychiatry 53 (2003) 39-47
51. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
52. Nugent A.C., Milham M.P., Bain E.E., Mah L., Cannon D.M., Marrett S., Zarate C.A., Pine D.S., Price J.L., and Drevets W.C. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30 (2006) 485-497
53. Perry E.K., Gibson P.H., Blessed G., Perry R.H., and Tomlinson B.E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34 (1977) 247-265
54. Petty F., and Sherman A.D. GABAergic modulation of learned helplessness. Pharmacol. Biochem. Behav. 15 (1981) 567-570
55. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., and Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32 (2007) 471-482
56. Represa A., and Ben-Ari Y. Trophic actions of GABA on neuronal development. Trends Neurosci. 28 (2005) 278-283
57. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., and Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56 (1999) 1043-1047
58. Sanacora G., Mason G.F., Rothman D.L., and Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry 159 (2002) 663-665
59. Santhakumar V., and Soltesz I. Plasticity of interneuronal species diversity and parameter variance in neurological diseases. Trends Neurosci. 27 (2004) 504-510
60. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 19 (1998) 500-505
61. Sonnewald U., Olstad E., Qu H., Babot Z., Cristofol R., Sunol C., Schousboe A., and Waagepetersen H. First direct demonstration of extensive GABA synthesis in mouse cerebellar neuronal cultures. J. Neurochem. 91 (2004) 796-803
62. Squire L.R., Stark C.E., and Clark R.E. The medial temporal lobe. Annu. Rev. Neurosci. 27 (2004) 279-306
63. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., Bernstein H.G., and Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42 (2008) 151-157
64. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 37 (2003) 357-373
65. Ströhle A., and Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36 Suppl 3 (2003) 207-214
66. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 57 (2005) 252-260
67. Woo T.U., Walsh J.P., and Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61 (2004) 649-657
68. World Health Organisation. Preventing Suicide: A Resource for General Physicians. Geneva (2000). http://www.who.int/mental_health/resources/suicide (http://www.who.int/mental_health/resources/suicide)
69. Zhang Z.J., and Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55 (2002) 1-10